All Therapeutic Areas
🩺
Gastroenterology
54 drugs in pipeline from 10 companies
54
Drugs in Pipeline
10
Companies
0
Upcoming Catalysts
54
Phase 3 Trials
Upcoming Catalysts
No upcoming catalysts found for Gastroenterology
Pipeline by Phase
Phase 3
54
Active Companies
CELG-RI
1 drugsBRISTOL MYERS SQUIBB CO
NVS
4 drugsNovartis AG
TEVJF
1 drugsTEVA PHARMACEUTICAL INDUSTRIES LTD
AMGN
1 drugsAmgen Inc.
GILD
1 drugsGilead Sciences, Inc.
PHM.MC
8 drugsPharmaMar, S.A.
AZNCF
3 drugsASTRAZENECA PLC
TAK
1 drugsTAKEDA PHARMACEUTICAL CO LTD
LLY
2 drugsEli Lilly and Company
ABT
4 drugsABBOTT LABORATORIES
Related Conditions
gastrointestinalgiliverhepaticcirrhosiscrohnulcerative colitisibsgerdpancreatitisceliacconstipationdiarrhea